ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/06/06 | 1,176 | 1,200 | 1,176 | 1,200 | +36 | +3.1% | 14,000 |
| 2012/06/05 | 1,155 | 1,164 | 1,150 | 1,164 | +10 | +0.9% | 9,000 |
| 2012/06/04 | 1,127 | 1,159 | 1,127 | 1,154 | +27 | +2.4% | 10,000 |
| 2012/06/01 | 1,118 | 1,127 | 1,118 | 1,127 | -21 | -1.8% | 11,000 |
| 2012/05/31 | 1,126 | 1,149 | 1,126 | 1,148 | +21 | +1.9% | 18,000 |
| 2012/05/30 | 1,155 | 1,155 | 1,120 | 1,127 | -28 | -2.4% | 16,000 |
| 2012/05/29 | 1,154 | 1,170 | 1,150 | 1,155 | -29 | -2.4% | 22,000 |
| 2012/05/28 | 1,183 | 1,184 | 1,153 | 1,184 | +12 | +1% | 15,000 |
| 2012/05/25 | 1,139 | 1,174 | 1,139 | 1,172 | +31 | +2.7% | 12,000 |
| 2012/05/24 | 1,175 | 1,175 | 1,119 | 1,141 | -38 | -3.2% | 21,000 |
| 2012/05/23 | 1,241 | 1,241 | 1,175 | 1,179 | -62 | -5% | 24,000 |
| 2012/05/22 | 1,238 | 1,267 | 1,237 | 1,241 | -8 | -0.6% | 17,000 |
| 2012/05/21 | 1,265 | 1,267 | 1,235 | 1,249 | -36 | -2.8% | 30,000 |
| 2012/05/18 | 1,290 | 1,290 | 1,267 | 1,285 | -25 | -1.9% | 18,000 |
| 2012/05/17 | 1,326 | 1,327 | 1,296 | 1,310 | -40 | -3% | 25,000 |
| 2012/05/16 | 1,432 | 1,432 | 1,340 | 1,350 | -106 | -7.3% | 30,000 |
| 2012/05/15 | 1,403 | 1,456 | 1,403 | 1,456 | +24 | +1.7% | 17,000 |
| 2012/05/14 | 1,433 | 1,433 | 1,421 | 1,432 | -2 | -0.1% | 9,000 |
| 2012/05/11 | 1,450 | 1,450 | 1,434 | 1,434 | -10 | -0.7% | 10,000 |
| 2012/05/10 | 1,427 | 1,450 | 1,427 | 1,444 | -8 | -0.6% | 7,000 |
| 2012/05/09 | 1,459 | 1,464 | 1,436 | 1,452 | -27 | -1.8% | 18,000 |
| 2012/05/08 | 1,451 | 1,479 | 1,451 | 1,479 | +24 | +1.6% | 6,000 |
| 2012/05/07 | 1,440 | 1,456 | 1,434 | 1,455 | -15 | -1% | 9,000 |
| 2012/05/02 | 1,460 | 1,480 | 1,459 | 1,470 | -5 | -0.3% | 23,000 |
| 2012/05/01 | 1,454 | 1,479 | 1,454 | 1,475 | +12 | +0.8% | 7,000 |
| 2012/04/27 | 1,478 | 1,479 | 1,460 | 1,463 | -14 | -0.9% | 20,000 |
| 2012/04/26 | 1,486 | 1,486 | 1,467 | 1,477 | +10 | +0.7% | 24,000 |
| 2012/04/25 | 1,437 | 1,480 | 1,437 | 1,467 | +30 | +2.1% | 15,000 |
| 2012/04/24 | 1,425 | 1,438 | 1,395 | 1,437 | +5 | +0.3% | 19,000 |
| 2012/04/23 | 1,430 | 1,443 | 1,422 | 1,432 | +2 | +0.1% | 8,000 |
| 2012/04/20 | 1,414 | 1,437 | 1,414 | 1,430 | +29 | +2.1% | 11,000 |
| 2012/04/19 | 1,408 | 1,415 | 1,400 | 1,401 | -20 | -1.4% | 18,000 |
| 2012/04/18 | 1,396 | 1,430 | 1,396 | 1,421 | +21 | +1.5% | 21,000 |
| 2012/04/17 | 1,409 | 1,410 | 1,400 | 1,400 | -5 | -0.4% | 10,000 |
| 2012/04/16 | 1,401 | 1,420 | 1,385 | 1,405 | -24 | -1.7% | 10,000 |
| 2012/04/13 | 1,440 | 1,448 | 1,429 | 1,429 | -2 | -0.1% | 13,000 |
| 2012/04/12 | 1,431 | 1,449 | 1,427 | 1,431 | -18 | -1.2% | 8,000 |
| 2012/04/11 | 1,459 | 1,459 | 1,449 | 1,449 | -6 | -0.4% | 5,000 |
| 2012/04/10 | 1,446 | 1,467 | 1,446 | 1,455 | -7 | -0.5% | 10,000 |
| 2012/04/09 | 1,445 | 1,463 | 1,445 | 1,462 | -10 | -0.7% | 6,000 |
| 2012/04/06 | 1,443 | 1,472 | 1,443 | 1,472 | +21 | +1.4% | 15,000 |
| 2012/04/05 | 1,452 | 1,467 | 1,446 | 1,451 | -11 | -0.8% | 7,000 |
| 2012/04/04 | 1,471 | 1,477 | 1,457 | 1,462 | -9 | -0.6% | 11,000 |
| 2012/04/03 | 1,447 | 1,480 | 1,447 | 1,471 | +6 | +0.4% | 14,000 |
| 2012/04/02 | 1,473 | 1,473 | 1,463 | 1,465 | -8 | -0.5% | 23,000 |
| 2012/03/30 | 1,480 | 1,480 | 1,470 | 1,473 | -11 | -0.7% | 16,000 |
| 2012/03/29 | 1,460 | 1,509 | 1,454 | 1,484 | +21 | +1.4% | 42,000 |
| 2012/03/28 | 1,448 | 1,475 | 1,422 | 1,463 | +5 | +0.3% | 55,000 |
| 2012/03/27 | 1,430 | 1,458 | 1,430 | 1,458 | +29 | +2% | 59,000 |
| 2012/03/26 | 1,430 | 1,435 | 1,425 | 1,429 | -1 | -0.1% | 26,000 |
3051～
3100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
